Champions Oncology provides end-to-end research and development solutions throughout the drug development lifecycle. From discovery research to clinical evaluation, Champions combines innovative technology and unrivaled expertise to enable more efficient drug discovery and development workflow. Its technology-enabled research platforms empower biopharma to create a comprehensive understanding of tumor cell biology, therapeutic dynamics and provide deep clinical insights. Champions Oncology was founded with the goal of utilizing ground breaking, well-characterized Patient-derived Xenograft Models (PDX Models) to test targeted therapies to identify potential therapeutic options for cancer patients. With clinical sites and laboratories strategically localized around the globe, Champions Oncology is able to obtain samples, coordinate studies worldwide and in turn, generate therapeutic testing results faster.